secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001779128-24-000062
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade Q1 net loss narrows to $4.2M; Medical revenue record $36M, up 34.6% YoY
-----------------------------------------------------------------------------

- Total Q1 revenue of $51.5M, up 13.8% YoY; Medical segment revenue hit a record $36.0M.
- Net loss improved to ($4.2M) from ($10.2M) a year ago; Adjusted EBITDA loss narrowed to ($3.5M).
- Medical Segment Adjusted EBITDA reached $4.4M (+134.5%); Passenger EBITDA loss improved to ($2.7M).
- Company reaffirms FY 2024 Adjusted EBITDA profitability and double-digit millions target for 2025.
- Gross profit margin expanded to 11.4% from 7.1%, driven by higher-margin Medical revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000177912824000062/0001779128-24-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000177912824000062/blde-20240507.htm
  HTML page:      https://secwatch.observer/filing/0001779128-24-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer